Medical Foods Market

Medical Foods Market (Product Type: Pills, Powder, Liquid, and Others; Route of Administration: Oral and Enteral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Medical Foods Market Outlook 2031

  • The global industry was valued at US$ 23.0 Bn in 2022
  • It is projected to grow at a CAGR of 7.5% from 2023 to 2031 and reach more than US$ 44.0 Bn by the end of 2031

Analysts’ Viewpoint

The global medical foods market experienced significant growth in the past few years, driven by increase in demand for specialized nutrition products that address specific medical conditions. Medical foods are specially formulated products that are intended for the dietary management of diseases and medical conditions that have unique nutritional requirements. Rise in prevalence of chronic diseases, such as diabetes, cancer, and Alzheimer's disease, is a major factor propelling market expansion. Increase in consumer interest in personalized nutrition is another factor bolstering market development.

Advances in technology and research on medical foods tailored to specific patient needs offer lucrative opportunities for market players. Manufacturers are focused on ensuring that medical foods are safe, effective, and accessible to patients.

Medical Foods Market

Medical Foods Market Introduction

Medical foods are specially formulated products that are intended for the dietary management of diseases and medical conditions that have unique nutritional requirements. Unlike conventional foods, medical foods are designed to be consumed under the supervision of a healthcare professional and are not typically available over the counter.

Medical foods are intended to provide targeted nutritional support to patients with specific medical needs. These could contain various ingredients, including vitamins, minerals, amino acids, and other nutrients, which are carefully selected to support the health and well-being of patients with specific medical conditions.

Some common examples of medical foods include products for the management of metabolic disorders, such as phenylketonuria (PKU), which requires a strict low-protein diet; and products for the management of neurological conditions, such as Alzheimer's disease, which may require increased intake of certain nutrients.

Medical foods are regulated by the U.S. Food and Drug Administration (FDA) and must meet certain criteria to be considered medical food. These criteria include being intended for the dietary management of a specific medical condition, used under medical supervision, and formulated to meet distinctive nutritional requirements.

Increase in Awareness about Importance of Nutrition

Increase in awareness about the importance of nutrition in managing health and well-being is driving the global medical foods business growth. This trend is driven by a range of factors, including rise in rate of chronic diseases, aging global population, and increase in demand for personalized nutrition.

The incidence rate of chronic diseases, such as diabetes, obesity, and heart diseases, has increased in the past few years. These conditions can often be managed through diet and nutrition. This has led to increase in demand for medical foods that are designed to support the management of these conditions. For instance, Nestle's Glucerna products are designed for people with diabetes and are formulated to help manage blood sugar levels.

Aging global population is another factor propelling market progress. The nutritional needs of people could change with age, and there is increasing demand for medical foods that can support these needs of older adults. For instance, Abbott Laboratories offers Ensure products, which are designed to provide complete nutrition for older adults who may have difficulty consuming conventional foods.

Increase in awareness about the importance of nutrition is a key driver of the global medical foods industry. As consumers become more educated about the role of nutrition in maintaining good health, they are seeking out specialized products that could address specific health concerns and conditions.

Medical foods are typically prescribed by healthcare professionals and are formulated to meet unique nutritional requirements that cannot be met by conventional foods alone. Demand for these foods is expected to continue to rise as the importance of nutrition in managing chronic diseases and conditions becomes better understood.

The regulatory environment for medical foods is an important factor fueling market expansion. In the U.S., the Food and Drug Administration (FDA) provides clear guidelines for the development and marketing of these foods. A favorable regulatory environment for these foods has encouraged investment in the sector and led to the development of a range of innovative products that could help manage different medical conditions. Investment in the development of medical foods has surged in the past few years, as companies strive to capitalize on the growing demand for personalized nutrition solutions.

Integration with Digital Health Technologies

Integration with digital health technologies is bolstering global medical foods market growth. Digital health technologies are used to improve patient outcomes by providing personalized nutrition recommendations and tracking patient progress. Mobile apps and wearables are used to track patient progress. These tools could help patients monitor food intake, track progress toward nutritional goals, and provide personalized recommendations based on individual needs. For instance, the Nutrino app uses artificial intelligence to create personalized meal plans and track nutrition data in real-time.

Digital health platforms are also used to connect patients with healthcare providers and nutritionists. These platforms allow patients to receive personalized nutrition advice from experts, and provide a convenient way for patients to track their progress and receive feedback. For instance, MyPlate by Livestrong app connects users with a nutrition coach who can provide personalized nutrition advice and track progress toward health goals.

Digital health technologies are also being used to develop new medical food products that are tailored to individual patient needs. For instance, Nutricia's FODMAP range of medical foods is designed to help people with irritable bowel syndrome, and is based on the results of a clinical trial that used a digital platform to identify patients who could benefit from a low FODMAP diet.

Ease of Use and Versatility Driving Powder Segment

In terms of product type, the powder segment dominated the global medical foods market in 2022 due to its ease of use and versatility. Powdered medical foods are a convenient way to provide complete nutrition to patients. These can be easily mixed with liquids or other foods to create different nutritional products.

One of the key advantages of powdered medical foods is convenience. Powdered products are easy to transport and store, and have a long shelf life. This makes them an ideal choice for patients who need to manage their nutrition over an extended period. These foods also offer high degree of flexibility in terms of dosing, as these could be easily adjusted to meet the individual needs of each patient.

Powdered medical foods are also versatile. These can be mixed with different liquids and foods to create customized nutritional products that meet the unique needs of each patient. For instance, these foods can be mixed with water or milk to create a drink, or these can be added to smoothies or other foods to boost their nutritional value.

Popularity of powdered medical foods is reflected in the growth of the segment. It is expected to dominate the global market in the next few years. The segment is likely to be driven by increase in demand for convenient and versatile nutritional products that can be tailored to individual patient needs.

Development of New Medical Foods Designed to Support Digestive Health

Based on disease type, the gastrointestinal disorders segment is expected to grow at a faster pace than other segments. This is ascribed to rise in prevalence of gastrointestinal disorders, increase in awareness about the importance of gut health, and development of new medical foods specifically designed to support digestive health.

Rise in prevalence of conditions, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and gastroesophageal reflux disease (GERD), is another key factor propelling the gastrointestinal disorders segment. These conditions could often be managed through dietary changes and usage of medical foods that are formulated to support digestive health. Therefore, demand for these foods that are designed to meet the specific nutritional needs of patients with gastrointestinal disorders is increasing.

Development of New Products Tailored to Specific Nutritional Needs

In terms of route of administration, the oral segment dominated the global medical foods market in 2022. The segment is projected to grow at a rapid pace during the forecast period. The segment includes medical foods that are designed to be taken orally, such as beverages, powders, and snacks. These products can be consumed by patients without the need for medical supervision, making them an ideal choice for patients who need to manage their nutrition at home or on-the-go.

Development of new products that are tailored to the specific nutritional needs of different patient populations is another factor driving the segment. For instance, oral medical foods that are designed to support the nutritional needs of patients with conditions such as diabetes, cancer, and malnutrition are now available in the market. These products provide a convenient way for patients to obtain the nutrients they need to support their health.

Increase in Focus on Preventive Healthcare

Based on distribution channel, the pharmacies & drug stores segment led the global medical foods market in 2022. The segment is expected to grow at a faster pace in the next few years. This segment includes medical foods that are sold through pharmacies and drug stores, either over-the-counter or with a prescription.

The pharmacies & drug stores segment is driven by increase in focus on preventive healthcare. As consumers become aware about the importance of nutrition in maintaining good health, they are seeking out medical foods that can help to prevent and manage health conditions. Pharmacies and drug stores are well-positioned to meet this demand, offering a range of medical foods that support different health needs.

Regional Outlook of Global Medical Foods Market

As per medical foods industry trends, North America accounted for the largest share of the global medical foods market in 2022. Rise in prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disease, is driving demand for these foods in the region. Additionally, increase in awareness about the importance of nutrition in maintaining good health and well-established healthcare infrastructure are ascribed to North America's global dominance.

Europe is also a significant market for medical foods, driven by increase in consumer awareness about health and wellness. Aging population and rise in demand for products that could support specific health conditions are expected to propel the market in the region in the next few years. Additionally, regulatory frameworks in Europe are supportive of the development and marketing of these foods.

The market in Asia Pacific is expected to witness significant growth during the forecast period. Rise in disposable income, increase in health-consciousness, and large population with chronic diseases are driving demand for medical foods in the region. Additionally, a growing middle class is expected to increase demand for these products. However, regulatory hurdles and lack of awareness about the benefits of these foods in some parts of the region are likely to hamper market growth.

Analysis of Key Players in Global Medical Foods Market

This report provides profiles of leading players operating in the global medical foods market. These include Nutricia (Danone), Nestlé S.A., Abbott Laboratories, Mead Johnson Nutrition, Fresenius Kabi, Friso, Morinaga Milk Industry, Primus Pharmaceuticals, Inc., Targeted Medical Pharma, Inc., and Medtrition, Inc. These players engage in merger & acquisition, strategic collaborations, and new product launches to expand presence and gain global medical foods market share.

Key Developments in Global Medical Foods Market

  • In February 2022, Nestle Health Science launched Peptamen 100 Cal with Fiber, a new medical food product designed for individuals with malabsorption and/or maldigestion issues. It contains 100 calories per 100 milliliters, along with prebiotic fibers that support digestive health, and is lactose-free, gluten-free, and low in residue to help with gastrointestinal tolerance.
  • In January 2022, Nutricia North America introduced a new medical food product, Periflex Junior Plus, specifically designed for children with intractable epilepsy. It is a ketogenic diet therapy that contains a balanced ratio of fat, carbohydrates, and protein, formulated to meet the unique nutritional needs of children with this medical condition.
  • On March 22, 2021, Abbott Laboratories introduced Glucerna Hunger Smart, a new medical food product for individuals with diabetes. It is designed to manage hunger by containing high-quality protein, slow-digesting carbohydrates, and fiber, which help control blood sugar levels and promote feelings of fullness. It is available in vanilla and chocolate flavors.

The report profiles the top players based on various factors including a company overview, financial summary, strategies, product portfolio, segments, and recent advancements in the market.

Global Medical Foods Market Snapshot

Attribute

Detail

Size in 2022

US$ 23.0 Bn

Forecast (Value) in 2031

More than US$ 44.0 Bn

Growth Rate (CAGR) 2023-2031

7.5%

Forecast Period

2023–2031

Historical Data Available for

2017–2022

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Product Type
    • Pills
    • Powder
    • Liquid
    • Others
  • Disease Type
    • Orphan Disease
      • Duchenne Muscular Dystrophy (DMD)
      • Sickle Cell Anemia
      • Hemophilia
    • Cancer
    • Neurological & Psychological Disorders
    • Metabolic Disorders
    • Pain Management
    • Gastrointestinal Disorders
    • Ophthalmology
    • Diabetes
    • Phenylketonuria (PKU)
    • Epilepsy
  • Route of Administration
    • Oral
    • Enteral
  • Distribution Channel
    • Pharmacies & Drug Stores
    • Online Channels
    • Supermarkets & Hypermarkets
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Nutricia (Danone)
  • Nestlé S.A.
  • Abbott Laboratories
  • Mead Johnson Nutrition
  • Fresenius Kabi
  • Friso
  • Morinaga Milk Industry
  • Primus Pharmaceuticals, Inc.
  • Targeted Medical Pharma, Inc.
  • Medtrition, Inc.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global medical foods market in 2022?

The global industry was valued at US$ 23.0 Bn in 2022

How big will the medical foods industry be in 2031?

It is projected to reach more than US$ 44.0 Bn by 2031

What will be the CAGR of the medical foods business during the forecast period?

The CAGR is anticipated to be 7.5% from 2023 to 2031

Which medical foods segment accounted for leading market share?

The powder segment held the largest share in 2022

Which region will account for major share during the forecast period?

North America is expected to account for the significant share during the forecast period.

Who are the prominent medical foods players?

Nutricia (Danone), Nestlé S.A., Abbott Laboratories, Mead Johnson Nutrition, Fresenius Kabi, Friso, Morinaga Milk Industry, Primus Pharmaceuticals, Inc., Targeted Medical Pharma, Inc., and Medtrition, Inc. are the prominent players in the market.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Medical Foods Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

    5. Key Insights

        5.1. Important market developments

        5.2. Top 3 Players Operating in the Market Space

        5.3. New competitive market entrants

        5.4. Medical food regulation overview

        5.5. Reimbursement Scenario

        5.6. Overview of the Distribution Channel of Medical Foods in various diseases along with examples

    6. Global Medical Foods Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. Pills

            6.3.2. Powder

            6.3.3. Liquid

            6.3.4. Others

        6.4. Market Attractiveness Analysis, by Product Type

    7. Global Medical Foods Market Analysis and Forecast, by Disease Type

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Disease Type, 2017–2031

            7.3.1. Orphan Disease

                7.3.1.1. Duchenne Muscular Dystrophy (DMD)

                7.3.1.2. Sickle Cell Anemia

                7.3.1.3. Hemophilia

                7.3.1.4. Others

            7.3.2. Cancer

            7.3.3. Neurological & Psychological Disorders

            7.3.4. Metabolic Disorders

            7.3.5. Pain Management

            7.3.6. Gastrointestinal Disorders

            7.3.7. Ophthalmology

            7.3.8. Diabetes

            7.3.9. Phenylketonuria (PKU)

            7.3.10. Epilepsy

        7.4. Market Attractiveness Analysis, by Disease Type

    8. Global Medical Foods Market Analysis and Forecast, by Route of Administration

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Route of Administration, 2017–2031

            8.3.1. Oral

            8.3.2. Enteral

        8.4. Market Attractiveness Analysis, by Route of Administration

    9. Global Medical Foods Market Analysis and Forecast, by Distribution Channel

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast, by Distribution Channel, 2017–2031

            9.3.1. Pharmacies & Drug Stores

            9.3.2. Online Channels

            9.3.3. Supermarkets & Hypermarkets

            9.3.4. Others

        9.4. Market Attractiveness Analysis, by Distribution Channel

    10. Global Medical Foods Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness Analysis, by Region

    11. North America Medical Foods Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017–2031

            11.2.1. Pills

            11.2.2. Powder

            11.2.3. Liquid

            11.2.4. Others

        11.3. Market Value Forecast, by Disease Type, 2017–2031

            11.3.1. Orphan Disease

                11.3.1.1. Duchenne Muscular Dystrophy (DMD)

                11.3.1.2. Sickle Cell Anemia

                11.3.1.3. Hemophilia

                11.3.1.4. Others

            11.3.2. Cancer

            11.3.3. Neurological & Psychological Disorders

            11.3.4. Metabolic Disorders

            11.3.5. Pain Management

            11.3.6. Gastrointestinal Disorders

            11.3.7. Ophthalmology

            11.3.8. Diabetes

            11.3.9. Phenylketonuria (PKU)

            11.3.10. Epilepsy

        11.4. Market Value Forecast, by Route of Administration, 2017–2031

            11.4.1. Oral

            11.4.2. Enteral

        11.5. Market Value Forecast, by Distribution Channel, 2017–2031

            11.5.1. Pharmacies & Drug Stores

            11.5.2. Online Channels

            11.5.3. Supermarkets & Hypermarkets

            11.5.4. Others

        11.6. Market Value Forecast, by Country, 2017–2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. Market Attractiveness Analysis

            11.7.1. By Product

            11.7.2. By Disease Type

            11.7.3. By Route of Administration

            11.7.4. By Distribution Channel

            11.7.5. By Country

    12. Europe Medical Foods Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017–2031

            12.2.1. Pills

            12.2.2. Powder

            12.2.3. Liquid

            12.2.4. Others

        12.3. Market Value Forecast, by Disease Type, 2017–2031

            12.3.1. Orphan Disease

                12.3.1.1. Duchenne Muscular Dystrophy (DMD)

                12.3.1.2. Sickle Cell Anemia

                12.3.1.3. Hemophilia

                12.3.1.4. Others

            12.3.2. Cancer

            12.3.3. Neurological & Psychological Disorders

            12.3.4. Metabolic Disorders

            12.3.5. Pain Management

            12.3.6. Gastrointestinal Disorders

            12.3.7. Ophthalmology

            12.3.8. Diabetes

            12.3.9. Phenylketonuria (PKU)

            12.3.10. Epilepsy

        12.4. Market Value Forecast, by Route of Administration, 2017–2031

            12.4.1. Oral

            12.4.2. Enteral

        12.5. Market Value Forecast, by Distribution Channel, 2017–2031

            12.5.1. Pharmacies & Drug Stores

            12.5.2. Online Channels

            12.5.3. Supermarkets & Hypermarkets

            12.5.4. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Spain

            12.6.5. Italy

            12.6.6. Rest of Europe

        12.7. Market Attractiveness Analysis

            12.7.1. by Product Type

            12.7.2. By Disease Type

            12.7.3. By Route of Administration

            12.7.4. By Distribution Channel

            12.7.5. By Country/Sub-region

    13. Asia Pacific Medical Foods Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017–2031

            13.2.1. Pills

            13.2.2. Powder

            13.2.3. Liquid

            13.2.4. Others

        13.3. Market Value Forecast, by Disease Type, 2017–2031

            13.3.1. Orphan Disease

                13.3.1.1. Duchenne Muscular Dystrophy (DMD)

                13.3.1.2. Sickle Cell Anemia

                13.3.1.3. Hemophilia

                13.3.1.4. Others

            13.3.2. Cancer

            13.3.3. Neurological & Psychological Disorders

            13.3.4. Metabolic Disorders

            13.3.5. Pain Management

            13.3.6. Gastrointestinal Disorders

            13.3.7. Ophthalmology

            13.3.8. Diabetes

            13.3.9. Phenylketonuria (PKU)

            13.3.10. Epilepsy

        13.4. Market Value Forecast, by Route of Administration, 2017–2031

            13.4.1. Oral

            13.4.2. Enteral

        13.5. Market Value Forecast, by Distribution Channel, 2017–2031

            13.5.1. Pharmacies & Drug Stores

            13.5.2. Online Channels

            13.5.3. Supermarkets & Hypermarkets

            13.5.4. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Market Attractiveness Analysis

            13.7.1. by Product Type

            13.7.2. By Disease Type

            13.7.3. By Route of Administration

            13.7.4. By Distribution Channel

            13.7.5. By Country/Sub-region

    14. Latin America Medical Foods Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product Type, 2017–2031

            14.2.1. Pills

            14.2.2. Powder

            14.2.3. Liquid

            14.2.4. Others

        14.3. Market Value Forecast, by Disease Type, 2017–2031

            14.3.1. Orphan Disease

                14.3.1.1. Duchenne Muscular Dystrophy (DMD)

                14.3.1.2. Sickle Cell Anemia

                14.3.1.3. Hemophilia

                14.3.1.4. Others

            14.3.2. Cancer

            14.3.3. Neurological & Psychological Disorders

            14.3.4. Metabolic Disorders

            14.3.5. Pain Management

            14.3.6. Gastrointestinal Disorders

            14.3.7. Ophthalmology

            14.3.8. Diabetes

            14.3.9. Phenylketonuria (PKU)

            14.3.10. Epilepsy

        14.4. Market Value Forecast, by Route of Administration, 2017–2031

            14.4.1. Oral

            14.4.2. Enteral

        14.5. Market Value Forecast, by Distribution Channel, 2017–2031

            14.5.1. Pharmacies & Drug Stores

            14.5.2. Online Channels

            14.5.3. Supermarkets & Hypermarkets

            14.5.4. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Market Attractiveness Analysis

            14.7.1. by Product Type

            14.7.2. By Disease Type

            14.7.3. By Route of Administration

            14.7.4. By Distribution Channel

            14.7.5. By Country/Sub-region

    15. Middle East & Africa Medical Foods Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Product Type, 2017–2031

            15.2.1. Pills

            15.2.2. Powder

            15.2.3. Liquid

            15.2.4. Others

        15.3. Market Value Forecast, by Disease Type, 2017–2031

            15.3.1. Orphan Disease

                15.3.1.1. Duchenne Muscular Dystrophy (DMD)

                15.3.1.2. Sickle Cell Anemia

                15.3.1.3. Hemophilia

                15.3.1.4. Others

            15.3.2. Cancer

            15.3.3. Neurological & Psychological Disorders

            15.3.4. Metabolic Disorders

            15.3.5. Pain Management

            15.3.6. Gastrointestinal Disorders

            15.3.7. Ophthalmology

            15.3.8. Diabetes

            15.3.9. Phenylketonuria (PKU)

            15.3.10. Epilepsy

        15.4. Market Value Forecast, by Route of Administration, 2017–2031

            15.4.1. Oral

            15.4.2. Enteral

        15.5. Market Value Forecast, by Distribution Channel, 2017–2031

            15.5.1. Pharmacies & Drug Stores

            15.5.2. Online Channels

            15.5.3. Supermarkets & Hypermarkets

            15.5.4. Others

        15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Market Attractiveness Analysis

            15.7.1. by Product Type

            15.7.2. By Disease Type

            15.7.3. By Route of Administration

            15.7.4. By Distribution Channel

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player - Competition Matrix (by tier and size of companies)

        16.2. Competitive Business Strategies

        16.3. Company Profiles

            16.3.1. Nutricia (Danone)

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Product Portfolio

                16.3.1.3. Financial Overview

                16.3.1.4. SWOT Analysis

                16.3.1.5. Strategic Overview

            16.3.2. Nestlé S.A.

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Product Portfolio

                16.3.2.3. Financial Overview

                16.3.2.4. SWOT Analysis

                16.3.2.5. Strategic Overview

            16.3.3. Abbott Laboratories

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Product Portfolio

                16.3.3.3. Financial Overview

                16.3.3.4. SWOT Analysis

                16.3.3.5. Strategic Overview

            16.3.4. Mead Johnson Nutrition

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Product Portfolio

                16.3.4.3. Financial Overview

                16.3.4.4. SWOT Analysis

                16.3.4.5. Strategic Overview

            16.3.5. Fresenius Kabi

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Product Portfolio

                16.3.5.3. Financial Overview

                16.3.5.4. SWOT Analysis

                16.3.5.5. Strategic Overview

            16.3.6. Friso

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Product Portfolio

                16.3.6.3. Financial Overview

                16.3.6.4. SWOT Analysis

                16.3.6.5. Strategic Overview

            16.3.7. Morinaga Milk Industry

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Product Portfolio

                16.3.7.3. Financial Overview

                16.3.7.4. SWOT Analysis

                16.3.7.5. Strategic Overview

            16.3.8. Primus Pharmaceuticals, Inc.

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Product Portfolio

                16.3.8.3. Financial Overview

                16.3.8.4. SWOT Analysis

                16.3.8.5. Strategic Overview

            16.3.9. Targeted Medical Pharma, Inc.

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Product Portfolio

                16.3.9.3. Financial Overview

                16.3.9.4. SWOT Analysis

                16.3.9.5. Strategic Overview

            16.3.10. Medtrition, Inc.

                16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.10.2. Product Portfolio

                16.3.10.3. Financial Overview

                16.3.10.4. SWOT Analysis

                16.3.10.5. Strategic Overview

    List of Tables

    Table 01: Global Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 02: Global Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031

    Table 03: Global Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017–2031

    Table 04: Global Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

    Table 05: Global Medical Foods Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

    Table 06: Global Medical Foods Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: Europe Medical Foods Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 08: Europe Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 09: Europe Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031

    Table 10: Europe Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031

    Table 11: Europe Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

    Table 12: Europe Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

    Table 13: North America Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 14: North America Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031

    Table 15: North America Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031

    Table 16: North America Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

    Table 17: North America Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

    Table 18: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 19: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031

    Table 20: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031

    Table 21: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

    Table 22: Asia Pacific Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

    Table 23: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 24: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031

    Table 25: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031

    Table 26: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

    Table 27: Latin America Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

    Table 28: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 29: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031

    Table 30: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031

    Table 31: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

    Table 32: Middle East and Africa Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

    List of Figures

    Figure 01: Global Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 02: Global Medical Foods Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 03: Global Medical Foods Market Revenue (US$ Mn), by Pills, 2017–2031

    Figure 04: Global Medical Foods Market Revenue (US$ Mn), by Powder, 2017–2031

    Figure 05: Global Medical Foods Market Revenue (US$ Mn), by Liquid, 2017–2031

    Figure 06: Global Medical Foods Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 07: Global Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031

    Figure 08: Global Medical Foods Market Attractiveness Analysis, by Disease Type, 2023–2031

    Figure 09: Global Medical Foods Market Revenue (US$ Mn), by Orphan Disease, 2017–2031

    Figure 10: Global Medical Foods Market Revenue (US$ Mn), by Cancer, 2017–2031

    Figure 11: Global Medical Foods Market Revenue (US$ Mn), by Neurological & Psychological Disorders, 2017–2031

    Figure 12: Global Medical Foods Market Revenue (US$ Mn), by Metabolic Disorders, 2017–2031

    Figure 13: Global Medical Foods Market Revenue (US$ Mn), by Pain Management, 2017–2031

    Figure 14: Global Medical Foods Market Revenue (US$ Mn), by Gastrointestinal Disorders, 2017–2031

    Figure 15: Global Medical Foods Market Revenue (US$ Mn), by Ophthalmology, 2017–2031

    Figure 16 Global Medical Foods Market Revenue (US$ Mn), by Diabetes, 2017–2031

    Figure 17: Global Medical Foods Market Revenue (US$ Mn), by Phenylketonuria (PKU), 2017–2031

    Figure 18: Global Medical Foods Market Revenue (US$ Mn), by Epilepsy, 2017–2031

    Figure 19: Global Medical Foods Market Value Share Analysis, by Route of Administration, 2022 and 2031

    Figure 20: Global Medical Foods Market Attractiveness Analysis, by Route of Administration, 2023–2031

    Figure 21: Global Medical Foods Market Revenue (US$ Mn), by Oral, 2017–2031

    Figure 22: Global Medical Foods Market Revenue (US$ Mn), by Enteral, 2017–2031

    Figure 23: Global Medical Foods Market Value Share Analysis, by Distribution Channel, 2022 and 2031

    Figure 24: Global Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2023–2031

    Figure 25: Global Medical Foods Market Revenue (US$ Mn), by Pharmacies & Drug Stores, 2017–2031

    Figure 26: Global Medical Foods Market Revenue (US$ Mn), by Online Channels, 2017–2031

    Figure 27: Global Medical Foods Market Revenue (US$ Mn), by Supermarkets & Hypermarkets, 2017–2031

    Figure 28: Global Medical Foods Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 29: Global Medical Foods Market Value Share Analysis, by Country, 2022 and 2031

    Figure 30: Global Medical Foods Market Attractiveness Analysis, by Country, 2023–2031

    Figure 31: North America Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 32: North America Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 33: North America Medical Foods Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 34: North America Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031

    Figure 35 North America Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031

    Figure 36: North America Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031

    Figure 37: North America Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022–2031

    Figure 38: North America Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 39: North America Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031

    Figure 40: Europe Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 41: Europe Medical Foods Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 42: Europe Medical Foods Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 43: Europe Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 44: Europe Medical Foods Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 45: Europe Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031

    Figure 46: Europe Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031

    Figure 47: Europe Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031

    Figure 48: Europe Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022–2031

    Figure 49: Europe Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 50: Europe Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031

    Figure 51: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 52: Asia Pacific Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 53: Asia Pacific Medical Foods Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 54: Asia Pacific Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031

    Figure 55: Asia Pacific Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031

    Figure 56: Asia Pacific Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031

    Figure 57: Asia Pacific Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022–2031

    Figure 58: Asia Pacific Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 59: Asia Pacific Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031

    Figure 60: Latin America Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 61: Latin America Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 62: Latin America Medical Foods Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 63: Latin America Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031

    Figure 64: Latin America Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031

    Figure 65: Latin America Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031

    Figure 66: Latin America Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022–2031

    Figure 67: Latin America Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 68: Latin America Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031

    Figure 69: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 70: Middle East and Africa Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 71: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 72: Middle East and Africa Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031

    Figure 73: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031

    Figure 74: Middle East and Africa Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031

    Figure 75: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022–2031

    Figure 76: Middle East and Africa Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 77: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031

Copyright © Transparency Market Research, Inc. All Rights reserved